Trial Details
COMPLETEDBasic Information
| Clinical ID | c4308 |
|---|---|
| Identifier | NCT00724529 |
| Trial Title | Post Marketing Surveillance of Remicade |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease|Ankylosing Spondylitis |
| Interventions | BIOLOGICAL: Infliximab |
Participant Information
| Sponsor | Janssen Korea, Ltd., Korea |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2007-06 |
|---|---|
| Primary Completion Date | 2011-08 |
| Completion Date | 2011-08 |